0001214659-21-003609.txt : 20210330 0001214659-21-003609.hdr.sgml : 20210330 20210330165727 ACCESSION NUMBER: 0001214659-21-003609 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210326 FILED AS OF DATE: 20210330 DATE AS OF CHANGE: 20210330 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Chang David D CENTRAL INDEX KEY: 0001611024 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38693 FILM NUMBER: 21787230 MAIL ADDRESS: STREET 1: C/O ALLOGENE THERAPEUTICS, INC. STREET 2: 210 EAST GRAND AVENUE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Allogene Therapeutics, Inc. CENTRAL INDEX KEY: 0001737287 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 823562771 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 210 EAST GRAND AVENUE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: (650) 457-2700 MAIL ADDRESS: STREET 1: 210 EAST GRAND AVENUE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 4 1 marketforms-52127.xml PRIMARY DOCUMENT X0306 4 2021-03-26 0001737287 Allogene Therapeutics, Inc. ALLO 0001611024 Chang David D 210 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080 true true false false President and CEO Common Stock 2021-03-26 4 A false 80452 0.00 A 2284869 D Common Stock 1201108 I See footnote Common Stock 650266 I See footnote Common Stock 650266 I See footnote Stock Option (Right to Buy) 33.78 2021-03-26 4 A false 298836 0.00 A 2031-03-26 Common Stock 298836 298836 D Securities held in the name of the Chang 2006 Family Trust. Securities held in the name of the JEC 2019 Trust dated October 1, 2019. Securities held in the name of the RTC 2019 Trust dated October 1, 2019. 25% of the shares subject to the stock option shall vest on March 13, 2022, and the remaining shares shall vest in 36 equal monthly installments thereafter. /s/ Veer Bhavnagri, Attorney-in-Fact 2021-03-30